Anil Joshi

Anil Joshi

Auto-generated profile, based on publicly available information

Anil Joshi

University Hospital Lewisham, England, United Kingdom of Great Britain and Northern Ireland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2021 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
SHSarah Humphries
Sarah Humphries
AJAnil Joshi
Anil Joshi
William Richard WebbWilliam Richard Webb
William Richard Webb
RKRahul Kanegaonkar
Rahul Kanegaonkar

5 August 2022 in Facial Plastic Surgery
Verified
Journal Article
Closed access
PDF file
AMAngelos Mantelakis
Angelos Mantelakis
KAKonstantinos Argiris
Konstantinos Argiris
AJAnil Joshi
Anil Joshi
ADAlwyn Ray D'SOuza
Alwyn Ray D'SOuza
The use of prophylactic antibiotics in the context of septorhinoplasty (SRP) is a frequently debated topic among plastic surgeons. Most surgeons routinely use antibiotics to prevent the dreaded physical and psychological morbidity of postoperative infections, although this practice is controversial. With antimicrobial resistance becoming a global threat, however, optimizing antibiotic prescribing is essential. The current evidence would suggest that the rate of postoperative infection is low and routine antibiotic use is unnecessary in SRP surgery. Rates range from 0.5 to 2% in simple SRP surgery, majority of which are minor nasal infections which respond to oral antibiotics and do not require hospital admission. In cases of complex SRP, defined as revision cases or where grafts or implants have been utilized, infection rates can be much higher with an incidence of 7 to 11%, and as such utilization of antibiotics is reasonable. When considering the regime to be utilized, a single preoperative dose of intravenous antibiotics has the same efficacy in reducing the incident of postoperative infection as a postoperative 7-day course of oral antibiotics. In the authors' practice, all patients receive a single intravenous dose of antibiotics on induction, and in the case of utilization of a graft from a nonnasal site, this is complimented with an oral course of postoperative antibiotics. With this approach, infections rates are at the lowest range of available published literature.

30 July 2026 in Facial Plastic Surgery
Verified
Journal Article
Closed access
CCChelsea Chan
Chelsea Chan
ANAlexander Scott North
Alexander Scott North
HMHamid Reza Khademi Mansour
Hamid Reza Khademi Mansour
YSYves Saban
Yves Saban
AJAnil Joshi
Anil Joshi
Introduction: Preservation rhinoplasty is an increasingly popular alternative to structural rhinoplasty. However, concerns remain regarding potential nasal airway narrowing and the limited availability of objective postoperative functional data. Objectives and Hypotheses: To review and analyse current studies assessing functional outcomes of preservation rhinoplasty, with or without comparison to structural rhinoplasty. Study Design: Systematic review and meta analysis of functional outcomes in preservation rhinoplasty. Methods: A comprehensive database search identified studies using key words. Eligible studies that were included reported original quantitative data using validated functional outcome measures (NOSE, SCHNOS-O, VAS-F, SNOT-22, or rhinometry). Results: Twenty-two studies (n = 2058) met inclusion criteria. Controlled studies showed no significant difference between preservation and structural rhinoplasty outcomes, while uncontrolled studies demonstrated postoperative improvement from baseline. Conclusions: Preservation and structural rhinoplasty yield comparable functional results, both significantly improving validated patient-reported outcome measures.

22 June 2026 in Facial Plastic Surgery
Verified
Journal Article
Closed access
SSSavan Shah
Savan Shah
TKTasnim Kamal
Tasnim Kamal
DNDaniel Ben Ner
Daniel Ben Ner
ADAlwyn D'SOuza
Alwyn D'SOuza
AJAnil Joshi
Anil Joshi
To summarize current evidence on Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) applications and outcomes in facial plastic surgery. PRP and PRF are autologous platelet concentrates with regenerative potential. They release growth factors that promote tissue repair, angiogenesis, extracellular matrix remodeling, graft integration, and scar remodeling, making them increasingly relevant in facial plastic surgery. A narrative review of clinical studies, meta-analyses, and systematic reviews was conducted. Key outcomes included wound healing, graft retention, postoperative edema and ecchymosis, scar improvement, and patient satisfaction. PRP improved wound healing, reduced crusting, and enhanced patient satisfaction in rhinoplasty, while PRF decreased cartilage resorption and improved graft stability. In rhytidectomy, PRP offered modest reductions in edema and ecchymosis. Both agents enhanced scar revision and fat graft outcomes, with PRF showing superior remodeling and long-term graft retention. In periorbital rejuvenation, PRP improved pigmentation and satisfaction, whereas PRF improved skin texture and wrinkles. Both were safe with minimal adverse events. PRP and PRF are effective biologic adjuncts in facial plastic surgery, supporting tissue regeneration, graft integration, and aesthetic outcomes. Efficacy is influenced by patient factors and technique. High-quality, procedure-specific trials are needed to optimize protocols.

1 October 2020 in Facial Plastic Surgery & Aesthetic Medicine
Verified
Journal Article
Closed access
SUSamit N. Unadkat
Samit N. Unadkat
PAPeter J. Andrews
Peter J. Andrews
Dario BertossiDario Bertossi
Dario Bertossi
ADAlwyn D'SOuza
Alwyn D'SOuza
AJAnil Joshi
Anil Joshi
HSHesham A. Saleh
Hesham A. Saleh
Facial Plastic Surgery & Aesthetic Medicine

14 September 2026 in Facial Plastic Surgery
Verified
Journal Article
Closed access
ANAlexander Scott North
Alexander Scott North
AJAnil Joshi
Anil Joshi
The objectives of this study are to examine the emerging role of personalized medicine in facial plastic surgery and to consider how biologically, anatomically, and psychologically tailored approaches may refine both aesthetic and reconstructive care. Facial plastic surgery has traditionally relied on anatomical principles, surgical expertise, and population-based evidence. Personalized medicine represents a shift toward more individualized care by incorporating patient-specific biological and phenotypic variation into clinical decision-making. Facial plastic surgery is uniquely dependent on subtle anatomical variation, soft tissue characteristics, wound healing behavior, and age-related change. These factors differ considerably between individuals and have a direct impact on both surgical planning and outcomes. Advances in genomics, pharmacogenomics, artificial intelligence, tissue engineering, and three-dimensional modelling are expanding the scope of personalized care. These technologies may improve prediction of healing, treatment response, complication risk, and reconstructive requirements. Personalized medicine may support more accurate patient selection by identifying those at increased risk of adverse scarring, variable response to injectables or pharmacotherapy, or differential reconstructive needs, thereby improving counselling and expectation management. Potential applications include tailored incision planning, individualized facial rejuvenation strategies, personalized perioperative pharmacological regimens, and patient-specific reconstructive scaffolds, grafts, and implants. Postoperative management may also become more individualized through better prediction of inflammatory response, scar formation, analgesic requirements, and recovery trajectory, allowing more precise surveillance and adjunctive treatment. Although many applications remain investigational, continued progress in regenerative medicine, molecular profiling, and predictive analytics is likely to accelerate clinical translation. Ethical challenges relating to privacy, bias, and equitable access must, however, remain central. Personalized medicine has the potential to enhance precision, safety, and patient-centered care in facial plastic surgery. Its future value will depend on thoughtful integration into practice as an adjunct to, rather than a replacement for, surgical judgement and aesthetic insight.